cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Guardant Health Inc
27 own
8 watching
Current Price
$31.07
$1.1
(3.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
3,361.36M
52-Week High
52-Week High
41.06000
52-Week Low
52-Week Low
15.81000
Average Volume
Average Volume
1.59M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization3,361.36M
icon52-Week High41.06000
icon52-Week Low15.81000
iconAverage Volume1.59M
iconDividend Yield--
iconP/E Ratio--
What does the Guardant Health Inc do?
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.
Read More
How much money does Guardant Health Inc make?
News & Events about Guardant Health Inc.
Business Wire
1 year ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it has been informed it will receive national reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW), effective July 24, 2023, for its Guardant360 CDx liquid biopsy test for...
Business Wire
1 year ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report additional data from its pivotal ECLIPSE study at Digestive Disease Week (DDW) on Tuesday, May 9, 2023. The company will host a webcast and conference call with primary investigators of the...
Business Wire
1 year ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, is pleased to announce that it will present data from two studies highlighting the performance of its blood-based screening technology to detect early-stage colorectal cancer (CRC), including the acceptance of the ECLIPSE...
Business Wire
1 year ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that it has submitted to the U.S. Food and Drug Administration (FDA) the final module of its premarket approval (PMA) application for Shield, Guardant Healths blood test to screen for colorectal cancer (CRC...
Globe Newswire
1 year ago
Prospective screening of subjects for ESR1 mutations will use the Guardant360 CDx blood test for companion diagnostic developmentPhase 3 study is supported by previously presented ELAINE-1 and ELAINE-2 Phase 2 study resultsSermonix anticipates dosing the first patient in first half of 2023 COLUMBUS...
Frequently Asked Questions
Frequently Asked Questions
What is Guardant Health Inc share price today?
plus_minus_icon
Can Indians buy Guardant Health Inc shares?
plus_minus_icon
How can I buy Guardant Health Inc shares from India?
plus_minus_icon
Can Fractional shares of Guardant Health Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Guardant Health Inc stocks?
plus_minus_icon
What is today’s traded volume of Guardant Health Inc?
plus_minus_icon
What is today’s market capitalisation of Guardant Health Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Guardant Health Inc?
plus_minus_icon
What percentage is Guardant Health Inc down from its 52-Week High?
plus_minus_icon
What percentage is Guardant Health Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$31.07
$1.1
(3.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00